Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis

BACKGROUND/AIMS: Studies have shown that nucleos(t)ide analogue (NA) treatment can reduce the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients, but it is unclear which NA is most effective. We performed a meta-analysis and systematic review comparing the efficacies of NAs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut Liver
Hauptverfasser: Wang, Xinhui, Liu, Xiaoli, Dang, Zhibo, Yu, Lihua, Jiang, Yuyong, Wang, Xianbo, Yang, Zhiyun
Format: Artigo
Sprache:Inglês
Veröffentlicht: Editorial Office of Gut and Liver 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7096226/
https://ncbi.nlm.nih.gov/pubmed/31158948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18546
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge